Go to Content

CaTe Inc.

CaTe Inc. logo

As of February 2024

City Year of Establishment Founder
Bunkyo-ku, Tokyo 2020 Kazuhiro Terashima
Partner VC Latest round of Fundraising Valuation
Jafco Group Co., Ltd. Series A JPY 1,115 million

  • Contact Information : 03-6273-8578
  • cate1@cate.co.jp
  • Website : a new window will openCaTe Inc.

Program name

Deep-Tech Startups Support Program

Research theme

Development of exercise workload optimization function and cardiac rehabilitation program medical device

Business Plan

Although cardiac rehabilitation has proven therapeutic benefits for patients with cardiac disease, participation in outpatient cardiac rehabilitation in Japan is low, at about 4-8%, resulting in many cardiac patients being repeatedly re-hospitalized, and society as a whole is burdened with medical costs. CaTe aims to create a healthier future by providing appropriate exercise therapy and behavior modification for a variety of patients, including those with cardiac disease, thereby creating an environment in which many patients can receive better medical care at home.

Research Outline

This research and development will develop a cardiac rehabilitation program medical device that will realize exercise therapy in a standing position that is both effective and safe by developing an exercise load volume optimization function.

  1. Development of the function to optimize the amount of exercise load
  2. Develop a cardiac rehabilitation program medical device equipped with (1)
  3. Conduct exploratory investigator-initiated trials
  4. Preparation of a validative clinical trial including protocol development.
Phase Business Area/Field Research Period Research Grant Amount
STS Healthcare 2023~2024 FY JPY 191 million

Last Updated : April 30, 2024